Solifenacin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Solifenacin and local guidelines before prescribing.

Antimuscarinic

Mechanism

Antimuscarinic selective for M3 receptors.

Uses

Overactive bladder.

Dosing

Side effects

Dry mouth, constipation, blurred vision, urinary retention, QT prolongation.

Interactions

CYP3A4 inhibitors raise levels; other anticholinergics additive.

Contraindications and cautions

Urinary retention, GI obstruction, glaucoma

Monitoring

Bladder emptying, cognition

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in severe renal or moderate liver impairment

Overdose and reversal

Physostigmine rarely

Special advice

Avoid in older people with cognitive impairment; consider mirabegron.

More from the textbook: uses, cautions and other points
Where it is discussed in the book